Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Total Liabilities (2016 - 2026)

Kewaunee Scientific (KEQU) has 15 years of Total Liabilities data on record, last reported at $119.2 million in Q4 2025.

  • For Q4 2025, Total Liabilities rose 58.65% year-over-year to $119.2 million; the TTM value through Oct 2025 reached $119.2 million, up 58.65%, while the annual FY2025 figure was $128.4 million, 63.46% up from the prior year.
  • Total Liabilities reached $119.2 million in Q4 2025 per KEQU's latest filing, down from $126.4 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $128.4 million in Q2 2025 and bottomed at -$37.0 million in Q4 2021.
  • Average Total Liabilities over 5 years is $78.6 million, with a median of $80.7 million recorded in 2023.
  • Peak YoY movement for Total Liabilities: tumbled 169.44% in 2021, then skyrocketed 327.29% in 2022.
  • A 5-year view of Total Liabilities shows it stood at -$37.0 million in 2021, then surged by 327.29% to $84.1 million in 2022, then dropped by 5.36% to $79.6 million in 2023, then dropped by 5.59% to $75.1 million in 2024, then surged by 58.65% to $119.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $119.2 million in Q4 2025, $126.4 million in Q3 2025, and $128.4 million in Q2 2025.